Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 10, 2017 (10 years ago)

Fluocinonide 0.05% Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: There are also CGMP Deviations.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

FLUOCINONIDE 0.05% SOLUTION, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

Drug: Fluocinonide

Recalling firm
Synergy Rx
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0538-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluocinonide recalls

See all
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-3 D-0477-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-2 D-0476-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-1 D-0475-2026
Class II · Moderate risk

Fluocinonide Topical Solution USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk

Fluocinonide Gel USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022

Other recalls by Synergy Rx

All 2017 recalls